Dihydralazine Sulfate Dihydrate is a direct-acting vasodilator used for hypertension, particularly in the acute management of hypertensive emergencies in pregnancy. Simson Pharma's Dihydralazine Sulfate Dihydrate reference standard and impurities support compendial testing for this obstetric antihypertensive.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Dihydralazine Sulfate Dihydrate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.